Your browser is no longer supported. Please, upgrade your browser.
Settings
INSY INSYS Therapeutics, Inc. daily Stock Chart
INSY [NASD]
INSYS Therapeutics, Inc.
Index- P/E68.27 EPS (ttm)0.52 Insider Own0.80% Shs Outstand71.43M Perf Week-0.67%
Market Cap2.54B Forward P/E28.00 EPS next Y1.27 Insider Trans-25.26% Shs Float23.87M Perf Month14.87%
Income38.30M PEG2.44 EPS next Q0.20 Inst Own42.50% Short Float65.84% Perf Quarter29.14%
Sales251.30M P/S10.09 EPS this Y-25.70% Inst Trans0.87% Short Ratio15.43 Perf Half Y68.41%
Book/sh2.60 P/B13.65 EPS next Y43.60% ROA19.10% Target Price36.38 Perf Year125.83%
Cash/sh1.42 P/C24.98 EPS next 5Y28.00% ROE24.80% 52W Range11.26 - 42.69 Perf YTD68.41%
Dividend- P/FCF73.29 EPS past 5Y17.30% ROI22.80% 52W High-16.84% Beta1.59
Dividend %- Quick Ratio2.50 Sales past 5Y- Gross Margin90.40% 52W Low215.28% ATR1.63
Employees382 Current Ratio3.10 Sales Q/Q70.20% Oper. Margin25.10% RSI (14)54.05 Volatility3.67% 4.71%
OptionableYes Debt/Eq0.00 EPS Q/Q10.00% Profit Margin15.20% Rel Volume0.54 Prev Close35.51
ShortableYes LT Debt/Eq0.00 EarningsAug 11 BMO Payout0.00% Avg Volume1.02M Price35.50
Recom2.00 SMA20-1.30% SMA5011.61% SMA20040.02% Volume553,335 Change-0.03%
Mar-09-15Reiterated RBC Capital Mkts Outperform $65 → $71
Mar-04-15Reiterated RBC Capital Mkts Outperform $57 → $65
Dec-15-14Reiterated RBC Capital Mkts Outperform $53 → $57
Nov-12-14Reiterated RBC Capital Mkts Outperform $51 → $53
Nov-12-14Downgrade Oppenheimer Outperform → Perform $40
Oct-02-14Initiated RBC Capital Mkts Outperform $51
Aug-14-13Reiterated Oppenheimer Outperform $23 → $27
Jul-31-13Initiated Oppenheimer Outperform $23
Jul-03-15 09:33AM  Thursday's After-Hours Movers: Sohu, Western Union, Insys Therapeutics, Affymetrix
Jul-02-15 01:35PM  7 Hot Growth Stocks that Have Outrun the Market in 1H15 - Analyst Blog
09:50AM  Clovis Oncology Starts Rolling NDA Submission for Rociletinib - Analyst Blog
Jun-29-15 10:34AM  10 Top U.S. Stocks to Keep Up the 1H Winning Streak - Analyst Blog
Jun-27-15 11:41AM  Why Marijuana and Your Money Are a Terrible Combination at Motley Fool
Jun-25-15 02:10PM  Medtronic's CoreValve Evolut R TAVR System Wins FDA Nod - Analyst Blog -7.74%
Jun-24-15 02:15PM  Boston Scientific Initiates Global Study on Emblem S-ICD - Analyst Blog -5.30%
Jun-22-15 05:36PM  2 IPO Leaders To Watch Poised Near Buy Points at Investor's Business Daily
Jun-17-15 08:00AM  Insys Therapeutics to Present at JMP Securities Life Sciences Conference 2015 Marketwired +7.04%
Jun-16-15 11:37AM  Medical Marijuana Takes A Hit After Supreme Court Ruling
Jun-15-15 05:27PM  Top Biotech Stock Files For New Drug, In Buy Range at Investor's Business Daily
Jun-12-15 07:47AM  Investor gives Insys room to run
Jun-10-15 08:50AM  Will Insys Therapeutics (INSY) Continue to Surge Higher? - Tale of the Tape
Jun-09-15 03:36PM  Apple is not ready to shine at MarketWatch
Jun-08-15 06:22PM  Top IPO Stock CyberArk Breaks Out, 2 Others In Bases at Investor's Business Daily
07:03AM  Splits Calendar: Insys Therapeutics splits before market open today (2:1 ratio)
07:00AM  Insys Therapeutics Completes Two-for-One Stock Split Through Stock Dividend Marketwired
Jun-02-15 07:00AM  Insys Therapeutics Submits NDA for Dronabinol Oral Solution Marketwired
May-28-15 08:02AM  Regeneron, Lannett Among The 4 Top-Rated Drug Stocks at Investor's Business Daily
May-22-15 01:04PM  INSYS THERAPEUTICS, INC. Financials
May-20-15 07:30AM  Insys Therapeutics to Present at Jefferies 2015 Healthcare Conference Marketwired
May-11-15 04:02PM  INSYS THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report
May-07-15 12:07PM  Insys Therapeutics beats 1Q profit forecasts
08:02AM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial S
07:07AM  Q1 2015 INSYS Therapeutics Inc Earnings Release - Before Market Open
06:57AM  Insys Therapeutics Reports First Quarter 2015 Results at noodls
06:50AM  Insys Therapeutics Reports First Quarter 2015 Results Marketwired
May-05-15 07:00AM  5 Hated Earnings Stocks You Should Love at TheStreet
Apr-30-15 10:44PM  Busted biotechs: by the numbers -6.74%
Apr-27-15 06:06PM  Nasdaq stocks posting largest percentage decreases -9.61%
Apr-23-15 05:05PM  Insys Therapeutics to Report First Quarter 2015 Results at noodls
04:30PM  Insys Therapeutics to Report First Quarter 2015 Results Marketwired
07:13AM  Insys Therapeutics Commences Dosing in Phase 1/2 Safety and Pharmacokinetic Study of Cannabidiol Oral Solution in Pediatric Epilepsy Patients at noodls
07:00AM  Insys Therapeutics Commences Dosing in Phase 1/2 Safety and Pharmacokinetic Study of Cannabidiol Oral Solution in Pediatric Epilepsy Patients Marketwired
Apr-17-15 06:00PM  Making Money With Charles Payne: 04/17/15 at Fox Business
Apr-13-15 12:25PM  Breakfast Of Champions: Is Pot Good For You?
Apr-08-15 11:42AM  Pfizer, Eli Lilly Were The Original Medical Marijuana Sellers at Forbes +9.92%
Apr-01-15 07:26PM  Lightning Round: Be careful-this lurks everywhere at CNBC
07:00PM  Cramer Remix: It's time to buy these oil stocks at CNBC
08:55AM  Marijuana Bill Gains Momentum In Congress
Mar-20-15 01:06PM  Cannabis companies: puffed up at Financial Times
Mar-19-15 03:12PM  The Marijuana CARERS Act: What You Need To Know
Mar-16-15 10:12AM  Marijuana: What A Difference Two Decades Makes
Mar-12-15 11:28AM  Marijuana Remains The 'Wild West' Of Investing
Mar-09-15 12:15PM  Marijuana Investment: Is It Time?
Mar-03-15 05:14PM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Princ
11:46AM  Insys Therapeutics Q4 Beat Drives Short-Lived Rally at Investor's Business Daily
08:51AM  INSYS Therapeutics Slumps: INSY Falls 7% in Session - Tale of the Tape
08:19AM  Insys Therapeutics tops 4Q revenue forecasts
07:25AM  Insys Therapeutics Reports Fourth Quarter and Year End 2014 Results at noodls
07:25AM  Insys Therapeutics Announces Its Pharmaceutical Cannabidiol Received Fast Track Designation From FDA for the Treatment of Dravet Syndrome at noodls
07:07AM  Q4 2014 Insys Therapeutics Inc Earnings Release - Before Market Open
07:00AM  Insys Therapeutics Reports Fourth Quarter and Year End 2014 Results Marketwired
06:00AM  Retail earnings, auto sales big for traders at CNBC
Mar-02-15 04:01PM  The Shuman Law Firm Investigates INSYS Therapeutics, Inc. Business Wire -6.96%
Feb-26-15 09:56AM  Medivation Tops Q4 Views On Strong Xtandi Results at Investor's Business Daily +5.67%
07:00AM  Insys Therapeutics Announces Its Pharmaceutical Cannabidiol Received Fast Track Designation From FDA for the Treatment of Dravet Syndrome Marketwired
Feb-25-15 07:56PM  The hot health care stocks to buy now for your 401(K) Fox Business Video
Feb-24-15 10:04AM  United Therapeutics Blood Pressure Drug Lifts Q4 at Investor's Business Daily
07:00AM  Insys Therapeutics In-Licenses Novel Mast Cell Therapy for Chronic Pelvic Pain Marketwired
Feb-17-15 04:30PM  Insys Therapeutics to Report Fourth Quarter and Year-End 2014 Results Marketwired
Feb-04-15 09:10AM  Earth Science Tech Building A Nutrition Empire Based On High Grade CBD and Nutraceutical Retailing Accesswire
Jan-26-15 08:00AM  Insys Therapeutics Receives FDA Orphan Drug Designation for Its Liposomal Encapsulated Paclitaxel for the Treatment of Ovarian Cancer Marketwired
Jan-23-15 08:54AM  Will Insys Therapeutics (INSY) Continue to Surge Higher? - Tale of the Tape Zacks
07:28AM  The Marijuana Market Is Expanding: Here Are A Couple Ways To Get Involved Benzinga
Jan-12-15 07:00AM  Insys Therapeutics to Initiate Five Phase III Clinical Trials in 2015 Marketwired +6.14%
Dec-30-14 09:53AM  Novus MedPlan Progress Exceeds Expectations, Company Poised For Banner 2015 Accesswire
Dec-18-14 02:52PM  Stocks Hold Near Session Highs; FedEx Bounces Back at Investor's Business Daily +8.25%
Dec-08-14 10:11AM  Novus Becomes an Insurance Leader as MMJ Market Approaches Tipping Point Accesswire
Dec-02-14 11:59AM  A Drug Maker Uses Doctors With Troubled Pasts to Promote a Painkiller at The Wall Street Journal
Nov-25-14 09:40AM  Insys' Cannabidiol Gets another Orphan Drug Designation Zacks
Nov-24-14 07:23AM  Cardica (CRDC) in Focus: Stock Moves Up 8.7% in Session Zacks
Nov-21-14 10:30AM  Insider Trading Alert - INSY, LNKD And IMPV Traded By Insiders at TheStreet
Nov-19-14 04:30PM  Insys Therapeutics to Present at 26th Annual Piper Jaffray Healthcare Conference Marketwired
Nov-17-14 05:42AM  Weakness Seen in Vascular Solutions (VASC): Stock Plunges 22.2% Zacks
Nov-15-14 06:33AM  The most dangerous medical marijuana myth at USA TODAY
Nov-14-14 06:05AM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online
Nov-12-14 10:00AM  Insys Therapeutics (INSY) Is Weak On High Volume Today at TheStreet
07:43AM  Insys Therapeutics downgraded by Oppenheimer Briefing.com
06:07AM  INSYS THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
05:27AM  INSYS Therapeutics (INSY) in Focus: Stock Rises 12% Zacks
Nov-11-14 06:02PM  Nasdaq stocks posting largest percentage increases AP +12.03%
04:16PM  Dow, S&P 500 close at record on Veterans Day at CNBC
11:33AM  Insys Q3 Beats Estimates, Helping Stock Rebound at Investor's Business Daily
11:04AM  Insys Therapeutics (INSY) Stock Soars Today on Third Quarter Earnings Beat at TheStreet
08:17AM  US stock futures add to gains; D.R. Horton reports at CNBC
08:11AM  Insys Therapeutics posts 3Q profit AP
07:07AM  Q3 2014 Insys Therapeutics Inc Earnings Release - Before Market Open CCBN
Nov-10-14 05:16PM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financi EDGAR Online
Oct-31-14 04:08PM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhi EDGAR Online
Oct-22-14 05:01PM  Biotechs Show Fed Chief's Not Much Of A Stock Analyst at Investor's Business Daily
Oct-16-14 06:01AM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
Oct-15-14 05:46PM  [$$] FDA Rejects Insys's Dronabinol Application at The Wall Street Journal +6.54%
Oct-06-14 09:00AM  Neutra Corp Doubles but Cannabis Stocks Move Largely Lower Last Week Accesswire -7.05%
Oct-02-14 12:03PM  Insys Therapeutics Up On Bullish Analyst Initiation at Investor's Business Daily +6.93%
Sep-18-14 09:55AM  Cannabis Technologies Looks to Diversify Pipeline with New Hire Accesswire
Sep-12-14 05:11PM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Other Events EDGAR Online
Sep-03-14 08:00AM  Insys Therapeutics, Inc. Named Arizona Bioscience Company of the Year Business Wire
Aug-26-14 03:30PM  Insys Therapeutics' Cannabidiol Gets Orphan Drug Status Zacks
Aug-25-14 10:17AM  FDA names potential Insys treatment an orphan drug AP
Insys Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes supportive care products. The company markets Subsys, a proprietary sublingual fentanyl spray for breakthrough cancer pain in opioid-tolerant cancer patients; and Dronabinol SG Capsule, a dronabinol soft gelatin capsule that is generic equivalent to Marinol, an approved second-line treatment for chemotherapy-induced nausea and vomiting, and anorexia associated with weight loss in patients with AIDS. Its products candidates also include Dronabinol Oral Solution, a proprietary orally administered liquid formulation of dronabinol. The company is headquartered in Chandler, Arizona.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Del Fosse FrancGeneral CounselJun 10Option Exercise13.2710,000132,70010,000Jun 10 05:56 PM
Del Fosse FrancGeneral CounselJun 10Sale34.4810,000344,8000Jun 10 05:56 PM
MEYER STEVEN JDirectorJun 05Sale63.005,000315,0000Jun 05 05:55 PM
Tambi BrianDirectorMay 27Option Exercise1.223,1003,7823,100May 27 06:14 PM
FOURTEAU PATRICKDirectorMay 27Sale60.141,31178,84454,841May 27 06:13 PM
Tambi BrianDirectorMay 27Sale60.093,100186,2790May 27 06:14 PM
Tambi BrianDirectorMay 26Option Exercise1.221,8002,1961,800May 27 06:14 PM
FOURTEAU PATRICKDirectorMay 26Sale60.004,784287,04056,152May 27 06:13 PM
Tambi BrianDirectorMay 26Sale60.001,800108,0000May 27 06:14 PM
Tambi BrianDirectorMay 20Option Exercise1.223,9004,7583,900May 20 05:28 PM
Tambi BrianDirectorMay 20Sale60.143,900234,5460May 20 05:28 PM
FOURTEAU PATRICKDirectorMay 20Sale60.006,095365,70060,936May 20 05:55 PM
Tambi BrianDirectorMay 19Option Exercise1.221,2001,4641,200May 20 05:28 PM
Tambi BrianDirectorMay 19Sale60.011,20072,0120May 20 05:28 PM
FOURTEAU PATRICKDirectorMay 19Sale60.002,969178,14067,031May 20 05:55 PM
BAKER DARRYL SChief Financial OfficerMay 18Sale59.1710,000591,7209,377May 18 04:02 PM
MEYER STEVEN JDirectorMay 11Option Exercise3.2518,00058,50023,000May 11 07:33 PM
MEYER STEVEN JDirectorMay 11Sale57.0618,0001,027,1605,000May 11 07:33 PM
Babich Michael LPresident and CEOMar 20Option Exercise3.255,00016,250207,752Mar 20 04:43 PM
Babich Michael LPresident and CEOMar 17Option Exercise7.2627,400198,924230,152Mar 18 04:49 PM
Babich Michael LPresident and CEOMar 17Sale57.7527,4001,582,441202,752Mar 18 04:49 PM
Babich Michael LPresident and CEOMar 16Option Exercise2.8277,600218,877250,352Mar 18 04:49 PM
Babich Michael LPresident and CEOMar 16Sale59.1347,6002,814,473202,752Mar 18 04:49 PM
FOURTEAU PATRICKDirectorMar 11Sale59.9410,000599,35970,000Mar 12 10:36 AM
STANLEY THEODORE HDirectorMar 10Option Exercise7.263,30023,9584,300Mar 10 04:47 PM
STANLEY THEODORE HDirectorMar 10Sale60.033,300198,0861,000Mar 10 04:47 PM
STANLEY THEODORE HDirectorMar 05Option Exercise7.266,70048,6427,700Mar 06 08:03 PM
STANLEY THEODORE HDirectorMar 05Sale60.116,700402,7461,000Mar 06 08:03 PM
BAKER DARRYL SChief Financial OfficerFeb 09Option Exercise7.268,75263,54028,129Feb 10 04:30 PM
BAKER DARRYL SChief Financial OfficerFeb 09Sale52.188,752456,71419,377Feb 10 04:30 PM
BAKER DARRYL SChief Financial OfficerFeb 06Option Exercise3.8021,24880,76040,625Feb 10 04:30 PM
BAKER DARRYL SChief Financial OfficerFeb 06Sale52.2521,2481,110,25019,377Feb 10 04:30 PM
Babich Michael LPresident and CEODec 19Option Exercise3.252,5008,125172,295Dec 22 04:42 PM
FOURTEAU PATRICKDirectorNov 19Sale39.1125,000977,67380,000Nov 20 05:43 PM
Babich Michael LPresident and CEONov 04Option Exercise2.367,50017,700177,295Nov 04 07:02 PM
Babich Michael LPresident and CEONov 04Sale37.277,500279,504169,795Nov 04 07:02 PM
Babich Michael LPresident and CEONov 03Option Exercise2.3672,500171,100242,295Nov 04 07:02 PM
Babich Michael LPresident and CEONov 03Sale38.8072,5002,813,223169,795Nov 04 07:02 PM
Babich Michael LPresident and CEOOct 21Option Exercise3.5420,00070,800189,795Oct 22 04:50 PM
Babich Michael LPresident and CEOOct 21Sale40.1720,000803,404169,795Oct 22 04:50 PM
Babich Michael LPresident and CEOOct 16Option Exercise3.255,00016,250165,562Oct 16 05:34 PM
STANLEY THEODORE HDirectorAug 13Buy33.933,000101,8005,100Aug 15 12:51 PM